Literature DB >> 5165106

In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097).

M I Marks, P Steer, T C Eickhoff.   

Abstract

Thirty-five strains of Torulopsis glabrata were tested by a tube dilution method for their susceptibility to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097). Amphotericin B was the most active in vitro, inhibiting all strains at a concentration of 1 mug/ml and killing all strains at 2 mug/ml. 5-Fluorocytosine inhibited over 80% of strains at 0.24 mug/ml, but three strains required >/=7.8 mug/ml for killing. A concentration of 2 mug of clotrimazole per ml inhibited less than 50% of strains, and 8 mug/ml killed only 10% of strains. Most strains of T. glabrata were killed by therapeutically achievable concentrations of amphotericin B and 5-fluorocytosine, but not clotrimazole.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5165106      PMCID: PMC377382          DOI: 10.1128/am.22.1.93-95.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  5 in total

1.  Laboratory identification of Torulopsis glabrata: typical appearance on routine bacteriological media.

Authors:  M I Marks; E O'Toole
Journal:  Appl Microbiol       Date:  1970-01

2.  BAY b 5097, a new orally applicable antifungal substance with broad-spectrum activity.

Authors:  M Plempel; K Bartmann; K H Büchel; E Regel
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

3.  Diagnosis of Torulopsis glabrata infection. Successful treatment of two cases.

Authors:  H Hahn; F Condie; R J Bulger
Journal:  JAMA       Date:  1968-03-04       Impact factor: 56.272

4.  Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine.

Authors:  M I Marks; T C Eickhoff
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

5.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06
  5 in total
  9 in total

1.  Standardized susceptibility testing of fluconazole: an international collaborative study.

Authors:  M A Pfaller; B Dupont; G S Kobayashi; J Müller; M G Rinaldi; A Espinel-Ingroff; S Shadomy; P F Troke; T J Walsh; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 2.  Clotrimazole: a review of its antifungal activity and therapeutic efficacy.

Authors:  P R Sawyer; R N Brogden; R M Pinder; T M Speight
Journal:  Drugs       Date:  1975       Impact factor: 9.546

3.  Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies.

Authors:  M A Burgess; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

4.  In vitro susceptibility of isolates of Aspergillus fumigatus and Sporothrix schenckii to amphotericin B.

Authors:  J W Brandsberg; M E French
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

5.  Collaborative investigation of variables in susceptibility testing of yeasts.

Authors:  M A Pfaller; M G Rinaldi; J N Galgiani; M S Bartlett; B A Body; A Espinel-Ingroff; R A Fromtling; G S Hall; C E Hughes; F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts.

Authors:  T Peng; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

Review 7.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

8.  Disk agar diffusion susceptibility testing of yeasts.

Authors:  M A Saubolle; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

9.  Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B.

Authors:  M F Mazens; G P Andrews; R C Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.